Clinical trial
A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer
NCT00557037 is registered in ClinicalTrials.gov with MEI Pharma, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer
- Lead sponsor
- MEI Pharma, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- November 30, 2009
- Enrollment
- 60 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer